Cullinan Therapeutics | 4:持股變動聲明-高管 Michaelson Jennifer
Cullinan Therapeutics | 4:持股變動聲明-高管 Fenton Mary Kay
Cullinan Therapeutics | 3:首次持股聲明-高管 Fenton Mary Kay
Cullinan Therapeutics | SC 13G:超過5%持股股東披露文件-Deerfield Mgmt, L.P.(5.71%),Deerfield Management Company, L.P.(5.71%)等
Cullinan Oncology | 3:首次持股聲明-高管 Nguyen Nate
Cullinan Oncology | 4:持股變動聲明-高管 Savill Corrine
Cullinan Oncology | 4:持股變動聲明-高管 AHMED NADIM
Cullinan Oncology | 4:持股變動聲明-高管 Michaelson Jennifer
Cullinan Oncology | 4:持股變動聲明-高管 SUMER JACQUELYN L
Cullinan Oncology | 4:持股變動聲明-高管 Trigilio Jeffrey
Cullinan Oncology | SC 13G:超過5%持股股東披露文件-Blue Owl Capital Holdings LP(7.99%)
Cullinan Oncology | SC 13G/A:超過5%持股股東披露文件(修正)-Morana Jovan-Embiricos(5.09%),Globeways Holdings II Ltd.(2.37%)等
Cullinan Oncology | SC 13G/A:超過5%持股股東披露文件(修正)-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
Cullinan Oncology | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(4.14%)
Cullinan Oncology | SC 13G:超過5%持股股東披露文件-Franklin Resources, Inc.(7.7%),Franklin Advisers, Inc.(7.6%)
Cullinan Oncology | 4:持股變動聲明-高管 Savill Corrine
Cullinan Oncology | 4:持股變動聲明-高管 Savill Corrine
Cullinan Oncology | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.8%)
Cullinan Oncology | 4:持股變動聲明-高管 Savill Corrine
Cullinan Oncology | 4:持股變動聲明-高管 AHMED NADIM
暫無數據